세계의 컴퓨터 보조 탐지(CAD) 시장 : 용도별(종양, 심장병), 양식별(유방촬영술, MRI, CT, 초음파), 최종사용자별(병원 및 클리닉, 영상진단센터, 외래진료센터) - 예측(-2031년)

Computer-aided Detection (CAD) Market by Application (Oncology [Breast, Lung, Colorectal, Liver], Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031

The Computer-aided Detection (CAD) market is projected to reach $1.56 billion by 2031 at a CAGR of 7.4% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditure. However, the high costs of CAD solutions restrain the growth of this market.

Furthermore, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate growth opportunities for the players operating in this market. However, the lack of technical expertise required to use CAD systems is a major challenge impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global Computer-aided Detection (CAD) market are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).

Among all the applications studied in this report, in 2024, the oncology segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns. Breast cancer ranks among the most prevalent cancers affecting women globally. According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040. The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.

Among all the imaging modalities studied in this report, in 2024, the mammography segment is expected to account for the larger share of the Computer-aided Detection (CAD) market. Computer-aided mammograms offer improved accuracy in diagnosis as the images can be zoomed in on, upgraded, or adjusted for more in-depth evaluation. Also, computer-aided mammography enables early identification of breast cancer in patients with no symptoms. These factors contribute to the segment's large share.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.

An in-depth analysis of the geographical scenario of the global Computer-aided Detection (CAD) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the Computer-aided Detection (CAD) market. In the region in 2024, the U.S. is expected to account for the largest share of the Computer-aided Detection (CAD) market in North America. The large share of this regional market is attributed to the presence of major Computer-aided Detection (CAD) companies such as GE HealthCare Technologies Inc. (U.S.), and Hologic, Inc. (U.S.), increasing cancer cases, and technological advancements in cancer detection and diagnosis.

Scope of the Report:

Computer-aided Detection (CAD) Market Assessment-by Application

• Oncology
  • Breast Cancer
  • Lung Cancer
  • Liver Cancer
  • Colon/Rectal Cancer
  • Prostate Cancer
  • Bone Cancer
  • Other Cancer Types
• Cardiology
• Other Applications

Note: Other applications include neurology, diabetic retinopathy, and tuberculosis.

Computer-aided Detection (CAD) Market Assessment-by Imaging Modality

• Mammography
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Ultrasound Imaging
• Other Imaging Modalities

Note: Other imaging modalities include X-ray imaging and endoscopy.

Computer-aided Detection (CAD) Market Assessment-by End User

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Ambulatory Care and Surgery Centers

Computer-aided Detection (CAD) Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Data Collection and Validation Process
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Rising Prevalence of Chronic Diseases
  • 4.2.2. Increasing Awareness Regarding the Importance of Early Cancer Diagnosis
  • 4.2.3. Increasing Investments and Funding for Cancer Research
  • 4.2.4. Rising Healthcare Expenditures
• 4.3. Restraints
  • 4.3.1. High Costs of CAD Solutions
• 4.4. Opportunities
  • 4.4.1. Growing Acceptance of CAD Among Radiologists
  • 4.4.2. Increase in Cancer Screening Programs
  • 4.4.3. Integration of Artificial Intelligence (AI) and Machine Learning (ML) into CAD Solutions
• 4.5. Challenges
  • 4.5.1. Lack of Technical Expertise Required to Use CAD Systems
• 4.6. Factor Analysis
• 4.7. Pricing Analysis
• 4.8. Market/Industry Trends
• 4.9. Porter's Five Forces Analysis

5. Computer-aided Detection (CAD) Market Assessment-by Application

• 5.1. Overview
• 5.2. Oncology
  • 5.2.1. Breast Cancer
  • 5.2.2. Lung Cancer
  • 5.2.3. Liver Cancer
  • 5.2.4. Colon/Rectal Cancer
  • 5.2.5. Prostate Cancer
  • 5.2.6. Bone Cancer
  • 5.2.7. Other Cancer Types
• 5.3. Cardiology
• 5.4. Other Applications

6. Computer-aided Detection (CAD) Market Assessment-by Imaging Modality

• 6.1. Overview
• 6.2. Mammography
• 6.3. Magnetic Resonance Imaging (MRI)
• 6.4. Computed Tomography (CT)
• 6.5. Ultrasound Imaging
• 6.6. Other Imaging Modality

7. Computer-aided Detection (CAD) Market Assessment-by End User

• 7.1. Overview
• 7.2. Hospitals & Clinics
• 7.3. Diagnostic Imaging Centers
• 7.4. Ambulatory Care and Surgery Centers

8. Computer-aided Detection (CAD) Market Assessment-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Rest of Asia-Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Industry Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Key Players' Market Share Analysis/Market Rankings (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 10.1. Siemens Healthineers AG
• 10.2. Koninklijke Philips N.V.
• 10.3. GE HealthCare Technologies Inc.
• 10.4. Hologic, Inc.
• 10.5. FUJIFILM Holdings Corporation
• 10.6. EDDA Technology, Inc.
• 10.7. Canon Medical Systems Corporation
• 10.8. Riverain Technologies
• 10.9. Median Technologies
• 10.10. Agfa-Gevaert NV
• 10.11. iCAD Inc.
• 10.12. CureMetrix, Inc.
• 10.13. THERAPIXEL

(Note: SWOT analyses of the top 5 companies will be provided.)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports